Please assess the completion status of the following clinical trial:

Trial Title: Radiation Induced Cystitis Treated With Hyperbaric Oxygen - A Randomized Controlled Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Provision of informed consent prior to any study specific procedures~* Female or male aged 18-80 years~* Intended curative radiation of the pelvic region as a treatment for cancer~* End of radiation therapy more than 6 months ago~* Radiation cystitis with Urological EPIC \< 80~* Radiation cystitis is the most probable cause for the patient's symptoms~Exclusion Criteria:~* Patients with major and ongoing bleedings from the bladder (requiring more than 0.5L blood-transfusion within the last four weeks)~* Refractory incontinence requiring catheter or surgical intervention~* Urine bladder capacity \< 100ml~* Fistula in the urine bladder~* Contraindications for HBOT according to the local centres routines~* Pregnancy~* Mechanical ventilator support~* Unable to follow and understand simple commands~* Not oriented to person, place and time

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- A - Immediate start (Type: ACTIVE_COMPARATOR): Start of treatment within 6 weeks of inclusion in the study. 100% oxygen at 240-250 kPa will be delivered to the patents for 80-90 minutes while sitting or lying in a hyperbaric oxygen chamber. Patients will receive treatment once every day, except week-ends, for 40 days.
- B - delayed start (Type: NO_INTERVENTION): Delayed start: Start of treatment not before 6 months of inclusion in the study. No intervention is given during the initial period.

Based on this trial design, predict the completion outcome and termination type (if applicable).